Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.1140
S.1140: Protecting Access to Biosimilars Act of 2019
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced April 11, 2019
- Latest Major Action April 11, 2019
Bill Sponsor
Bill Version
- Introduced in Senate - April 11, 2019
Bill Summary
Protecting Access to Biosimilars Act of 2019 This bill excludes biological products that were initially licensed under the Federal Food, Drug, and Cosmetic Act (FD&C Act) (e.g., insulin) from the exclusivity protections that delay the licensure of biosimilar products under the Public Health Service Act (PHS Act). (The Biologics Price Competition and Innovation Act of 2009 generally requires that biological products approved under the FD&C Act...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| April 11, 2019 |
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|
| April 11, 2019 |
Introduced in the Senate by Tina Smith (D-Minn.) |